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Abstract. Antibiotic resistance is not solely a medical but also a social problem, inﬂuenced partly by patients’
treatment-seeking behavior and their conceptions of illness andmedicines. Situatedwithin the context of a clinical trial of
C-reactive protein (CRP) biomarker testing to reduce antibiotic over-prescription at the primary care level, our study
explores and compares the narratives of 58 fever patients in ChiangRai (Thailand) andYangon (Myanmar). Our objectives
are to 1) compare local conceptions of illness andmedicines in relation to health-care seeking and antibiotic demand; and
to 2) understandhow these conceptions could inﬂuenceCRPpoint-of-care testing (POCT) at the primary care level in low-
and middle-income country settings. We thereby go beyond the current knowledge about antimicrobial resistance and
CRPPOCT, which consists primarily of clinical research and quantitative data. We ﬁnd that CRP POCT in Chiang Rai and
Yangon interacted with fever patients’ preexisting conceptions of illness and medicines, their treatment-seeking be-
havior, and their health-care experiences, which has led to new interpretations of the test, potentially unforeseen
exclusion patterns, implications for patients’ self-assessed illness severity, and an increase in the status of the formal
health-care facilities that provide the test. Although we expected that local conceptions of illness diverge from inbuilt
assumptions of clinical interventions, we conclude that this mismatch can undermine the intervention and potentially
reproduce problematic equity patterns among CRP POCT users and nonusers. As a partial solution, implementers may
consider applying the test after clinical examination to validate rather than direct prescription processes.
INTRODUCTION
Antimicrobials have been considered the basis of modern
medicine and are one of the most frequently purchased drug
types globally, but their effectiveness is challenged by grow-
ing antimicrobial resistance (AMR).1–3 Not only high-income
but also low- and middle-income countries (LMICs) are af-
fected by AMR because it can compromise the management
of leading causes of death such as gastrointestinal, re-
spiratory, sexually transmitted, and nosocomial infections.4
Several national governments and international organizations
have thus declared AMR as a global health emergency.3
This article addresses AMR from a social perspective, fo-
cusing speciﬁcally on patients’ antibiotic use against the
backdrop of antibiotic resistance (ABR; a subset of AMR). We
know from the anthropological literature that patients’ con-
ceptions of illness and medicines inﬂuence their health-care
seeking and medicine use. Yet, our understanding of the
social dimensions of ABR remains surprisingly narrow—
indicated by the persistent narrow focus of national and global
AMR policies on awareness raising (rather than e.g., socio-
economic drivers of resistance such as poverty), by repeated
calls for more social research into AMR in general5–7 and by a
social science share of only 0.53% out of 17,675 documents
with the key words “AMR” according to the Scopus database
(as of July 31, 2017).8 The social research gap is problematic
because it affects how we think about the increasing global
efforts to curb AMR.
Among these efforts are calls for rapid diagnostic tests
(RDTs) such as C-reactive protein (CRP; a blood test marker
for inﬂammation) point-of-care testing (POCT) to inform
health-care workers’ (HCWs) antibiotic prescription decisions
in LMICs.9–11 By indicating whether infections have bacterial
or nonbacterial causes, clinical research compares the po-
tential role of CRP POCT to malaria RDTs, which can help re-
ducepatient uptakeof unnecessary antimalarial treatment.12,13
However, the anthropological literature on malaria RDTs has
cautioned repeatedly that local conceptions of malaria, social
relationships, and treatment-seeking behavior can inﬂuence
test effectiveness, stimulate heterogenous forms of use, and
entail unforeseenandpotentially adverse consequences for the
users.14–16 C-reactive protein point-of-care testing may in-
teract similarly with the conceptions and behaviors of patients
and health-care providers, but we know little about any such
social consequences.
Our objective is to contribute to the social understanding of
ABR and its proposed remedies through a comparative
qualitative study of fever patients’ health perceptions in the
LMIC settings of Chiang Rai (Thailand) and Yangon (Myan-
mar), where CRP POCT has been trialed. Drawing on themes
from the medical anthropology and qualitative clinical re-
search literature, our analysis indicates that local conceptions
of illness and medicine do interact with CRP POCT and entail
distinctive interpretations, reproduce existing patterns of
health-care exclusion, and could lead to potentially risky
treatment-seeking behaviors.
LITERATURE AND FRAMEWORK
Related literature. By studying the social context of AMR
and CRP POCT, we draw, especially, on the medical anthro-
pology literature. This body of work shares an interest in the
varied meanings and manifestations of medicine use, which
can have implications for the development of and efforts to
address AMR.6 For example, a common theme in the medical
anthropological literature on AMR is that patients’ conceptions
of illness and medicines contribute to locally idiosyncratic
* Address correspondence to Yuzana Khine Zaw, Department of
Global Health and Development, London School of Hygiene and
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patterns of antibiotic use as people use medicines to treat
symptoms rather than diseases.17
The symbolic meaning surrounding medicine can further inﬂu-
encepatternsofusewithinasocietywhenphysicalattributes (e.g.,
color, taste, appearance, and mode of application) are inter-
preted across cultural contexts.18 More generally, the medical
anthropology literature suggests that local conceptions are
an important driver in medicine use and health behavior and
consequently warrant study for antibiotic use in particular.
By virtue of being locally speciﬁc, conceptions of medicine
and illness—and their implications for AMR-relevant health
behavior—vary across social contexts. As our study takes
placeacross twoLMICsettings,wealso speak to comparative
qualitative social research on health-care–seeking behavior.
Comparative social research in health is not uncommon, but
broader knowledge about the cross-contextual variations of
local conceptions and health-care–seeking patterns in the
context of AMR could help to situate the usefulness and ef-
fectiveness of remedial action and interventions across
(cultural) borders.19–22 Therefore, our ﬁrst research question
contributes to the social understanding of AMR through a
comparative study of Yangon and Chiang Rai: How do local
conceptions of illness andmedicine inﬂuence context-speciﬁc
health-care–seeking patterns in Chiang Rai and Yangon?
Our second research question speaks to the limited so-
cial understanding of CRP POCT. The existing literature
explores, primarily questions of clinical efﬁcacy through quan-
titative research, thus characterizing CRP POCT as effective in
reducing unnecessary antibiotic prescription in high-income
contexts.10,23–25 Despite the growing interest in CRPPOCT to
reduce over-prescription of antibiotics and to slow the de-
velopment of ABR, qualitative research has lagged behind
its quantitative counterpart.26 The existing qualitative litera-
ture on CRP POCT is limited to high-income contexts and
has a clinical focus with an interest in the acceptability of the
CRP POCT by studying users’ and patients’ attitudes and
perceptions.27–32 Contrary to what the medical anthropolog-
ical literature suggests, this body of work does not address
more fundamental social questions relating to the uses and
meanings surrounding antibiotic use, which may interact and
interfere with the introduction of a point-of-care test. Our
second research question corresponds to this social research
gap: How do local conceptions of illness and medicines in-
teract with CRP POCT in primary care settings?
Analytical framework.Westructuredouranalysisaccording
to themes derived from medical anthropology and qualita-
tive clinical research on CRP POCT (summarized in Figure 1.
Our analytical strategy for Research Question 1 explored how
local conceptions of illness and medicines inﬂuence health-
care–seeking behavior (e.g., self-diagnosis and treatment
choices) and the resulting patterns of access to health care
and medicine from formal and informal health-care providers
(under the heading “analytical framework” in Figure 1). Speciﬁc
themes from the anthropological literature, for example, lay
deﬁnitions ofmedicine, formed our initial analytical categories.6
Analyzing and juxtaposing these analytical domains for Chiang
Rai and Yangon thereby helped us to address the lack of
comparative qualitative evidence on AMR-related conceptions
of illness and behavior. Our analytical strategy for Research
Question 2 involved examining the relationship between CRP
FIGURE 1. Analytical framework and themes for analysis developed from three bodies of literature.
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POCT and the salient themes of Research Question 1, for ex-
ample, the interaction between CRP POCT and local con-
ceptions of illness. We also related this analysis to themes in
the qualitative CRP POCT literature, the limited breadth of
which required us to incorporate complementary themes
from the medical anthropology literature on malaria RDT. In
short, our analysis commenced with 1) understanding the
case contexts, followed by 2) examining local conceptions
and treatment-seeking behavior among patients in our ﬁeld
sites, and 3) situating the CRP POCT within these concep-
tions and behaviors to detect potentially unintended inter-
actions and interferences.
MATERIALS AND METHODS
Study design.We conducted cross-sectional qualitative so-
cial research thatcomplementedaclinical trial on the introduction
ofCRPPOCT inprimaryhealthservices in theoutskirtsofYangon
and Chiang Rai between July 2016 and July 2017. Both sites are
AMR priority areas, having reported speciﬁc forms of resistance
(e.g., scrub typhus in Chiang Rai, Mycobacterium tuberculosis
isolates in Yangon) and exhibiting a high risk of ABR through
human antibiotic use.33–36 The clinical trial focused on antibiotic
prescription behavior of HCWs (i.e., medical doctors in Yangon
and nurses inChiangRai). The trial involved 1,200 febrile patients
(600 adults/children) per country, who were recruited at three
clinics (operated by a nongovernmental organization [NGO]) and
one public primary care hospital in Yangon, and at six primary
care units in Chiang Rai. The patients were randomized into two
treatment groups with different CRP cutoff levels to guide anti-
biotic prescription, and one control group. At their ﬁrst visit, the
treatment groups watched a short educational video about CRP
POCT and the lacking necessity to take antibiotics for viral
infections,† received the 5-minute CRP POCT, and carried out a
urine test (control groups provided urine samples, venous blood
samples, and nasopharyngeal swabs). Study nurses/doctors
conducted these activities and presented the CRP POCT results
to the HCWs to inform their prescription decisions. All trial par-
ticipants were shown posters and received information during
the consent process to acquaint them with CRP POCT, all re-
ceived the CRP POCT at their second visit after 5 days to vali-
date the HCW’s treatment decision, and all had a second
follow-up visit at Day 14 with questions on recovery.
The social research study complemented the clinical trial to
understand the social context of CRP POCT implementation.
As we applied anthropological concepts, an ethnographic re-
search design would have been ideal.37 However, time con-
straints imposed by the parallel clinical trial and the probable
inﬂuence of participant observation methods on the study
setting prevented such a design. We, therefore, conducted a
cross-sectional qualitative study (designed and led by a social
scientist, viz.M. J.H.),which studied the test introduction at the
interface betweenpatients and health systems andwhich drew
on theoretical strands from medical anthropology (treatment-
seeking behavior), political sciences (street-level bureaucracy),
and sociology (actor-network theory). We present the over-
arching ﬁndings of the social study elsewhere and report in the
present article a substudy that analyzes in detail the relation-
ships between CRP POCT and patients’ treatment-seeking
behavior across two implementation contexts.
Data collection and analysis. Semistructured interviews
(SSIs) and focus group discussions (FGDs), with a total of
92 participants, including febrile patients and HCWs, were
conducted leading to 84:35 hours of recorded material and
936,000 words of original-language transcriptions, transla-
tions, and ﬁeld notes. This article focuses on the patient data
from37participants fromChiangRai (25SSIs and three FGDs)
and 21 participants from Yangon (11 SSIs, two FGDs; sum-
marized in Table 1).‡This patient sample involved participants
of both the treatment and the control groupsof the clinical trial,
plus a group of nonintervention fever patients who had not
participated in the clinical study (whom we sampled through
separate logs kept at the health centers). The volume of this
data corresponds to 44 hours of recorded and 494,000 words
ofwrittenmaterial. The patientswere sampledpurposefully for
maximum variation across the dimensions of age, gender,
education, study group, and antibiotic prescription.
Our thematic analysis builds on the preformulated themes
described in Figure 1 and on new themes that emerged from
ourqualitativedata.38 The thematic codingwas iterative, using
NVivo11 (QSR International Pty Ltd., Melbourne, Australia).39
Translation ambiguities were minimal as our research team
includedBurmese and Thai native speakers.We ﬁrst analyzed
the data set based on local conceptions of illness to explore
the landscape of meaning within which patients act. Second,
we traced popular terminologies that patients used to de-
scribe these conceptions, which helped illustrate how con-
ceptions and health-care–seeking patterns are linked. Last,
we explored how these conceptions and health-seeking
patterns could relate to CRP POCT and reasons why some
patients may not receive the test. Our comparative analysis
further considered the nature and emergence of themes and
sub-themes across and within the case contexts.
RESULTS
Case study context.Chiang Rai is a northern Thai province
with 1.1 million inhabitants in 2000, 12.5% of whom belong to
minority groups, including hill tribes.40 Thailand achieved
Universal Health Coverage (UHC) in 2002 and met all health-
related targets of the millennium development goals by the
early 2000s.41 Its geographically dispersed health infrastructure
allows near-universal access to public primary health centers
and district hospitals.42 In addition, Thailand carries out antibi-
otic stewardship activities through campaigns such as the
“Antibiotic Smart Use” (ASU) program aimed at “promoting ra-
tional use of medicines” by introducing a set of interventions on
individual (e.g., prescribing herbal medicine for nonbacterial in-
fections), network (e.g., sharing lessons learnt), and policy levels
(e.g., implementing ASU-related policies at hospitals).43,44
In comparison, Yangon, Myanmar’s ex-capital and its most
populous city with 7.4 million inhabitants (Department of
Population, 2015), has a less developed health system.Health
care is provided through both the private and public sectors,
but ﬁnanced predominantly by out of pocket expenditure
(50.7% of total expenditure on health as compared with
11.9% in Thailand in 2014).45,46 A national health plan
(2017–2021) was recently publishedwith the goal of achieving
UHC by 2030 (Ministry of Health and Sports, 2017).47 Yet,
†The video is available at https://youtu.be/hJnxSwbqWOE.
‡The Yangon data are lesser in volume because it was collected
speciﬁcally for a comparative analysis.
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decades of neglect of the health sector have left the Burmese
health system behind its Southeast Asian counterparts, visi-
ble, for example, in low levels of health expenditure per capita
of US$20 in 2014 (Thailand: US$228, Malaysia: US$456, and
Vietnam: US$142).46 The unstructured nature of the squatter
settlements and the emergence of private and unregulated
health-care providers within the Yangon study site make the
landscape yet more obscure and difﬁcult to navigate. In ad-
dition, there is little stewardship from the government in terms
of addressing ABR, with no existing national antibiotic-related
policy to date.
Overall, antibiotic access and use is high in Chiang Rai and
Yangon, with a large contribution from the private and informal
sectors.48,49 Differences between the settings emerge in terms
of health system development and socioeconomic conditions,
where the Chiang Rai site shows improved living conditions,
more inclusive health-care access, and a higher level of an-
tibiotic stewardship. Recent data from primary care facilities
thereby indicate a decrease of antibiotic prescriptions to
outpatients from 30% to 12% in Thailand (2010–2015) and
an increase from 38% to 47% in Myanmar.50 Figure 2 sum-
marizes the similarities and differences between the sites.
Research question 1: local conceptions of illness
and medicines. As might be expected, we observed a link be-
tween self-perceived severity and health-care–seeking behav-
ior.51 However, local conceptions of illness etiologies emerged as
important correlates because they were intrinsically linked to pa-
tients’ symptoms and their self-assessed severity (illustrated in
Figure 3A). The three broad categories of illness etiologies de-
scribed by patients in both settings were environmental (e.g., ill-
ness caused by the weather), behavioral (e.g., working too hard),
and microbial (e.g., unspeciﬁed “germs” and “microbes”).
Patients typically linked fevers and mild associated symp-
toms such as headaches to environmental and behavioral
causes, whereas they related illnesses with a suspected mi-
crobial origin to symptoms that require treatment (e.g., sore
throats).§ The ensuing health-care choices were linked
systematically to this assessment. For example,wherepatients
considered a fever to have environmental or behavioral causes,
their remedial health action would include changing the be-
haviors that allegedly caused the fever, or self-treatment using
“paracetamol” and other “fever reliever” medicine. Behavioral
adjustments were for instance reported by a male patient in
Yangon,whoexplained thathewouldnotbuyandusemedicine
during a fever that was caused by “lack of sleep” and instead
“take some rest in bed, in hopes that I will get better.” In con-
trast, patients linked more serious symptoms such as sore
throats or fevers withmultiple symptoms (e.g., pain) to external
disease-causing agents such as germs, microbes, viruses, or
worms. The subsequent health-care choices would reportedly
involvemedicines speciﬁcally “to kill germs” or “to stop [germs]
fromspreading” and thus “protect the body.”For instance, one
Yangon respondent indicated that, “I think that fever also has
germs so there would be germ killer [i.e., antibiotic] for fever.”
Parallel to (and partially overlapping with) local conceptions
of illness etiology, lay deﬁnitions of medicine deviated from
clinical deﬁnitions and appeared to exert an inﬂuence on pa-
tients’ health-care–seeking behavior as well (Figure 3B). For
example, in Yangon, the most frequently used terms to de-
scribe medicines to treat fever and related symptoms were
“microbe/germ killer,” “fever reliever,” “pain reliever,” and
unspeciﬁed cocktails of “mixed medicine.” Among these, the
term (poe thet say) was the common colloquial
reference to antibiotics among both lay people and clinicians,
directly translating into “microbe killer” or “germ killer.”
“Germs” in this case can refer to a broad range of agents,
which maybe bacterial and nonbacterial (e.g., viruses or
pests). In contrast, fever patients in Chiang Rai described their
medicines with a broader range of terms, including “anti-
inﬂammatory medicine,” “germ killer,” “cough medicines,”
“fever reliever,” “pain reliever,” and “stomach ache medicine.”
The terms (yah kae ak seb or “anti-inﬂammatory
medicine”) and occasionally also (yah kah chuea or
“germ killer”) were colloquially used to refer to antibiotics.
The intuition underlying these local deﬁnitions can poten-
tially invite antibiotic over-use for conditions with non-bacterial
causes. For example, in Chiang Rai, sore throat was described
as “a wound in the throat that is constantly wet” or as a “red
throat, inﬂamed throat” that would be treated thus with “anti-
inﬂammatory medicine”—that is, antibiotics. In Yangon, the
term “germ killer” (i.e., antibiotics) was commonly linked to
germs that cause fever, ﬂu, sore throat, rashes, and other
TABLE 1
Sample summary of interview and focus group participants in Chiang Rai and Yangon
a) Semi-structured interview (SSI) participants b) Focus group discussion (FGD) participants
Yangon Chiang Rai Total SSI participants Yangon Chiang Rai Total FGD participants
Age (years) 18–49 9 21 30 6 7 13
50+ 3 6 9 3 3 6
Sex Female 8 17 25 5 7 12
Male 4 10 14 4 3 7
Education £ 6th grade 3 17 20 1 3 4
> 6th grade 9 10 19 4 7 11
Study group CRP POCT treatment 6 13 19 5 4 9
CRP POCT control 2 8 10 3 3 6
Nonintervention 4 6 10 1 3 4
Received antibiotic during treatment Yes 2 13 15 4 6 10
No 6 14 20 3 4 7
Grand total 12 27 39 9 10 19
CRP = C-reactive protein; POCT = point-of-care testing.
§Note that we are not implying that patients assessed different
causes of illnesses as differently severe. Although they were
systematically linked to severity and health-care choices, our
interviews suggest that the assessment was based on symptoms
and other factors such as disease duration, rather than their notions of
etiology. Note that “symptoms requiring treatment” are not limited to
microbial origins.
1664 KHINE ZAW AND OTHERS
conditions such as arthritis. The wide range of potential uses
for antibiotics could be related to the term (poe or “germ”),
which includesmicrobial agents such as viruses and bacteria
alongside pests and insects. The term “germ killer” can,
therefore, refer to pesticides and to antibiotics. In short,
where the implied logic of vernacular descriptions of medi-
cine deviates from their clinical deﬁnition (and our interviews
suggest that this is the rule rather than an exception), pa-
tients might access antibiotics for an unexpectedly wide
range of symptoms and uses.
Patients, therefore, appeared to be more likely to take an-
tibiotics knowingly or unknowingly when their conceptuali-
zation of antibiotics aligned with the perceived nature of their
illness (be it fever or other acute conditions), or when it was
deemed to have microbial causes. However, time and re-
source constraints in both sites often meant that these pa-
tients accessed medicine through the informal sector, and
formal providers, typically, only if private treatment options
were unaffordable or if symptoms persisted or worsened. The
ﬁrst resort of care might thus potentially involve unsupervised
antimicrobial use, accessed through the informal sector.
When formal health-care access actually did take place, pa-
tients in both sites expressed that they “want to feel better
quickly” and “trust” the public and private HCWs, but also that
they wished to know more about their health but did not re-
ceive this information.
Our qualitative analysis, therefore, suggests that our
Chiang Rai and Yangon sites shared a common underlying
pattern in which patients’ local conceptions of illness etiol-
ogies and antibiotics were linked directly and indirectly to
health-care–seeking behavior, including behavioral adjust-
ments, self-treatment, and in-/formal provider access, together
with expectations of antibiotics for symptoms and conditions
beyond their clinical deﬁnition. The manifestations of these
conceptions varied with the local health systems and provider
landscapes across our ﬁeld sites, but we describe in the fol-
lowing section that they have common implications for the in-
troduction of CRP POCT to guide primary-care-level antibiotic
prescription.
Research question 2: relationship between CRP POCT
and local conceptions. The introduction of CRP POCT in
Chiang Rai and Yangon interacted with patients’ conceptions
of illness etiologies, with their assessment of how severe the
illness is, with the ensuing health-care choices and, last, with
their health-care experiences in the formal health-care sector
(summarized in Figure 4). These interactions inﬂuence pa-
tients’ conceptions of CRP POCT (Interaction 1 in Figure 4),
severity assessments (Interactions 2 and 3), exclusion of
speciﬁc patients and symptoms from CRP POCT (Interaction
4 and 5), and the perception of the primary care facilities who
provideCRPPOCT (Interaction6). Although these interactions
emerged consistently across our two ﬁeld sites, patients’
education contributed to additional within-site variation.
A range of patients had a vague notion that CRP POCT
related tomedicine prescription, but four distinct conceptions
about the test emerged among our respondents:
Conception 0: Patient does not know purpose of the test
(common)
Conception 1: A test that distinguishes bacterial from non-
bacterial causes of infection (rare)k
Conception 2: A test for speciﬁc diseases that patients typi-
cally deem “serious,” such as syphilis, diabetes, dengue, tu-
berculosis (TB), or human immunodeﬁciency virus (common)
Conception 3: A comprehensive blood test to detect any
disease in the human body (common){
Although all these conceptions emerged in both ﬁeld sites,
they varied across patients’ education levels. This relationship
was not straightforward, however. Chiang Rai patients with
FIGURE 2. Summary of case context similarities and variations.
kThis category only comprised patients in the treatment groups who
mentioned occasionally the terms “bacteria” and “virus” andwho saw
educational video material about the CRP POCT. However, the
patients’ narratives suggest that the terms entered their vocabulary
and connected and resonated with existing notions gained from the
media, but they did not integrate into existing conceptions of illness
and remained passive thus.
{Although it might be expected, Conceptions 2 and 3 were not
exclusive to patients who actually received an intravenous blood test
in addition to CRP POCT (but who typically did not learn the results
thereof).
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primary education or below had a wide range of interpretations
of CRP POCT (e.g., Conceptions 2 and 3), whereas patients
with secondary and higher education in Yangon related to
Conception 1 and to conceptions that are at odds with CRP
POCT’s clinical intentions (e.g.,Conception2). These emerging
patterns suggest that CRPPOCT inclusion andadherencemay
have social gradients within one implementation setting.
Beyond education, conceptions of microbial illness etiolo-
gies and their severity assessment appeared to inﬂuence in-
terpretations of CRP POCT as a test for speciﬁc diseases
(Conception 2) or as a comprehensive blood test (Conception
3). C-reactive protein point-of-care testing in our case studies
was provided in formal primary care facilities, to which pa-
tients often resorted for illnesses with persistent symptoms or
that cater to “serious” infections potentially caused by
“germs.” Patients, therefore, appeared to associate the test
with serious speciﬁc conditions (Conception 2). Thismay have
also inﬂuenced the interpretation as a test to detect microbes
in the body (Conception 3), considering that “microbes” did not
only include bacteria but also germs, worms, or pests in the
local vernacular, and thatpatients inChiangRaiandYangondid
not necessarily differentiate between these explicitly. Conse-
quently, patients in both sites were “relieved” or “happy”when
testednegative, forexample, a female respondent fromYangon
receiving the CRP POCT stated that “When I got the results
from the doctor, he said that it’s all good, so I am happy, just
scared that theymight ﬁndsomething in the blood.”Wesee this
as evidence of a plausible inﬂuence of local conceptions of
illnesson the interpretationof theCRPPOCTbeyond its clinical
intentions (Interaction 1, Figure 4), of an association of the test
with more severe conditions that require treatment in formal
health-care facilities (Interaction 2) and, conversely, an effect of
the test in reassuring patients that they did not have a serious
illness (Interaction 3).
Furthermore, CRP POCT interacts with people’s treatment
choices as 1) the delivering health-care facilities are not
equally available for all patients (Interaction 4) and 2) the logic
of distinguishing bacterial from nonbacterial fevers (or re-
spiratory infections) can exclude a potentially wide range of
antibiotic-seeking behaviors for other symptoms within and
beyond the formal health-care setting (Interaction 5). Patients
in both ﬁeld sites lamented access constraints to the formal
health-care services that provide CRPPOCT. For instance, an
older female respondent in Chiang Rai postponed access to
thehealth center for 2weeksbecause “therewasnoone [in her
household] to take me there,” and respondents in Yangon
alluded to long travel times and high costs to access the CRP
POCT facilities, because of which “there are times where we
miss the appointments.” Resource and time constraints may,
therefore, bias formal health-care utilization toward priority
members of the family—especially children. Patientswhomay
only seek informal health services formild illnesseswould then
be less likely to receive CRP POCT, which appeared to be a
common case in Yangon’s more fragmented health-care
system where unlabeled medicine cocktails (“mixed medi-
cine”) from a nearby drug shop would cost as little as 3% as a
FIGURE 3. Link between local conceptions of illness etiology, local conceptions of medicine, and health-care choices for fevers and associated
symptoms.
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journey to a free-of-charge clinic participating in the CRP
POCT trial according to our respondents. Yet, even if patients
do access formal health-care services, the internal logic of the
CRPPOCTmay exclude a range of patients with expectations
to receive antibiotics for illnesses outside of the scope of the
test. It was for instance common in Chiang Rai that patients
expected “anti-inﬂammatory medicine” (i.e., antibiotics) for
sore throats but not for fevers (the focal inclusion criterion of
theCRPPOCT trial), whereas other patients reported that they
had received antibiotics at health centers because of “bumps
frommosquito bites” and “when it’s bad. If I havemuscle pain”
(for which they would not be CRP tested).
Last, amongpatientswho receivedCRPPOCT, almost all had
favorable opinions of the test and stated that they trusted the
HCW’s diagnosis more with the test. Yet, these patients did not
favor the test because of its intrinsic purpose but rather because
they receivedmore time,attention,andexplanations fromHCWs
(a similar pattern emerged among the control group of the study,
from whom a venous blood sample was taken). For instance,
good treatment was often related to “a careful checkup,”
whereas clinics with poor treatment “don’t have enough time . . .
and then send us off (. . .without giving us) time to ask (questions
about what is wrongwith us).”Because CRPPOCT intervention
typically added a set of extra procedures and 5–10 minutes to
total consultation time according to our observations in the ﬁeld,
respondents in the intervention groups considered that treat-
ment is “betterwith theblood test.They (HCWs) takecareof you”
and stated explicitly that “I like that they (the hospital doing CRP
POCT) check the urine and the blood.” Treatment decisions
based on CRP POCT results were also deemed more “precise”
and “sophisticated,” especially in Chiang Rai where fewer pa-
tients had previously experienced point-of-care testing at pri-
mary care facilities (contrary to the NGO clinics in Yangon
specializing in TB and sexually transmitted diseases). These
impressions suggest that CRP POCT elevated the status of
primary care HCWs without necessarily leading patients to ap-
preciate its intrinsic nature, given that patients consistently de-
veloped different interpretations of the test in line with their
preexisting conceptions of illness (Interaction 6).
DISCUSSION
Limitations. Before we continue with discussing the impli-
cations of our study, it is important to highlight research limita-
tions related to sampling and researcher positionality. First, our
sample cannot represent the Chiang Rai and Yangon pop-
ulationsbecause it comprised fever patientswith formal primary
health-care access. Our ﬁndings are, therefore, prone to mis-
representing subpopulations who would normally seek antibi-
otic treatment of other symptoms or diseases such as muscle
pain or urinary tract infections, or who do not access primary
health services either by choice or other constraints (e.g., pov-
erty). We used a purposive maximum variance sampling strat-
egy to include a diverse patient pool and mitigate the impact of
patientmisrepresentation.52 In addition, our interviews included
questions on the health-care provider landscape, health-care
choices, andother illness episodesof our respondents and their
peers beyond fever andprimary health service utilization. This is
only a partial remedy. Our study, however, enables a ﬁrst
glimpse into how AMR-relevant conceptions of illness and
medicinemaycompare acrossneighboring LMICcontexts, and
how they interact or interferewith external interventions such as
CRPPOCT.Further researchwouldbroadenour understanding
of the nuances and common patterns in people’s antibiotic-
related conceptions and behaviors.
The research also faces positionality challenges as differ-
ent researchers participated in different stages of the re-
search process.53 For instance, the overarching clinical study
was led by a health economist in collaboration with medical
researchers; the social sciences substudy was headed by a
European social scientist with a background in development
studies,whowasassistedbycentral Thai andYangonBurmese
research assistants. This structure often led the social research
team to be perceived as medical researchers despite explicit
and repeated assurances to the patients that we were not
medical doctors. More generally, the involvement of various
researcherswith their own preconceptions andpositions bears
the risk of distorting patients’ voices. Our approach to ensuring
an authentic and trustworthy account of our informants’
FIGURE 4. Interactions between local conceptions, treatment-seeking behavior, and C-reactive protein point-of-care testing (CRP POCT).
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narratives involved regular team discussions and reﬂexive ex-
ercises to understand each members’ positions and the chal-
lenges they faced during the research process, and triangulating
of the data analysis across researchers and data types (ﬁeld
notes, SSIs, and FGDs).54 However, these remedial actions
cannot rule out a residual bias introduced through our positions
as outsiders from our speciﬁc study communities.
Relation to the literature. Our research reinforces existing
themes in the general andRDT-speciﬁcmedical anthropology
literature, whereas also hypothesizing new mechanisms un-
derlying the emergence of potentially unforeseen interpreta-
tions and implications of medical interventions such as CRP
POCT. For example, our comparative analysis echoesmedical
anthropology themes such as the symbolism and lay deﬁni-
tions of medicine.6,18,55 To an extent, our study also reﬂects
themes from the malaria RDT literature, such as conceptions
of POCT as a comprehensive blood test to detect illnesses
and the satisfaction of patient demand for knowledge and
elevated trust in HCWs when a test is used.56–59
Yet, our study also adds to knowledge by identifying local
conceptionsof illnessetiologies andpatients’ self-assessmentof
their illness severity as criticalmechanisms leading to unforeseen
interpretations and consequences of CRP POCT. Spanning
varied conceptions of CRP POCT; behavioral implications of
negative testing; exclusion from the test for speciﬁc target
groups, symptoms, andhealth-care choices; and thesatisfaction
of health-care demands without appreciating the intervention for
its intrinsic purposes, we have established an arrangement of
social consequences of CRP POCT that forms a coherent yet
deviant system of conceptions and action. C-reactive protein
point-of-care testing is an active element of this system that
contributes to health-care–seeking practices and new forms of
health-care inclusion and exclusion. Considering that these im-
plications materialize consistently across two LMIC case con-
texts, we see scope in applying our framework to other social
research studies aiming to understand interactions between
preexisting local conceptions and medical interventions.
Implications for CRP POCT. C-reactive protein point-of-
care testing may have different consequences for patients
who were able to access the test and patients who were ex-
cluded. Included patients could potentially beneﬁt from the
direct purpose of the test by not receiving antibiotics un-
necessarily for non-bacterial infections. The satisfaction of
knowledge demands (through receiving test results) and
higher health-care satisfaction (through more time, attention,
and procedures devoted to patients) could also stimulate
increased formal health-care utilization and, therefore, less
risky health behaviors for this group. However, not all patients
included into CRP POCT would realize these beneﬁts. For
example, less educated people in Chiang Rai and more edu-
cated people in Yangon had more varied conceptions about
CRP POCT. Some of these conceptions considered CRP
POCT as a test for speciﬁc diseases such as diabetes or as a
general comprehensive blood test to detect any disease in
humans. Where this is the case, patients may potentially in-
terpret negative test results as “everything is normal” and
being free of disease, and adjust their health behavior ac-
cordingly (this would not be problematic for a common cold,
but consider e.g., a hypothetical diabetic patient believing he
or she is free of diabetes after a negative test result).
Although it would not entirely resolve risky behaviors and
unforeseen interpretations of CRP POCT, a partial remedy
may be to emphasize HCW-to-patient communication during
HCW’s CRPPOCT training, drawing on local notions of illness
when explaining the test to patients and asking the patients to
re-explain the purpose of the test. The critical reader may
observe that such a suggestion cannot be derived solely from
patient perspectives, considering for instance the extensive
anthropological research on malaria RDT, which pointed at
numerous factors including experience with and availability of
other diagnostic tests, expectations of positive test results, or
time constraints when HCWsmake and communicate POCT-
based prescription decisions.14,15 We acknowledge this limi-
tation and note that our own research with HCWs in Yangon
and Chiang Rai (reported elsewhere, using a street-level bu-
reaucracy approach to study behavior within the context of
pressure from guidelines and patient demands) indicated a
vast range of antibiotic prescription and nonprescription be-
havior, andHCWs in both settings used colloquial (e.g., “germ
killer” in Yangon) and technical terms when referring to anti-
biotics. This suggests that HCWs may share the same in-
terpretation and world views of the community although also
facing constraints from policy and patients that could render
lengthy communication with the patient infeasible.# Although
our analysis of patient perspective, therefore, suggests that
the articulation and explanation of conceptions of CRP POCT
during the consultation could aid with reducing anxiety and
risky behaviors, there is little doubt that such an approach
would require further ethnographic research of the patient–
HCW encounter in the context of CRP POCT.
Problematicmight alsobe the implications forpatientswhoare
excluded from CRP POCT. On the one hand, CRP POCT might
simply mirror other interventions that align with the “inverse care
law,” adding to a portfolio of formal primary care services that are
inaccessible to marginalized populations.60 On the other hand, a
distinctive form of exclusion may arise from the mismatch be-
tween local conceptions of illnesses requiring antibiotic treat-
ment, and the diagnostic focus of CRP POCT. In the case of the
clinical trial alongside which our study took place, the focus on
febrilepatientsmayhaveexcluded thosewhoexpectedantibiotic
treatment of a sore throat ormuscle pain at the same health-care
facility. Should CRP POCT become a standard procedure in the
future, a possible avenue worth exploring may, therefore, be to
test after clinical examination if this indicates that antibiotics are
needed. Although this solutionwould require clinical validation of
the CRP POCT for a wider range of health conditions, it could
potentially avoid amismatch with local expectations for primary-
care-level antibiotic treatment in the absence of bacterial infec-
tions, for example, for muscle pains.
CONCLUSION
Antimicrobial resistance is a global health issue, and point-
of-care biomarker tests are among the portfolio of proposed
solutions to address the over-prescription of antibiotics for
diseaseswithout bacterial causes. This article aimed to expand
our understanding of the social context ofCRPPOCT testing in
LMICs.Wehavebuilt ananalytical frameworkbasedonexisting
themes in the medical anthropology and qualitative clinical re-
search literature, and applied it successfully to a unique quali-
tative data set collected alongside the introduction of CRP
#We thank an anonymous reviewer for raising this point.
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POCT at formal primary health-care facilities in Chiang Rai
(Thailand) and Yangon (Myanmar). We ﬁnd that local concep-
tions of illness are the foundation from which a wide range of
interpretations of CRP POCT, distinctive patterns of exclusion,
and new treatment-seeking behaviors emerge. Although our
study suggests that future CRP POCT interventions may ben-
eﬁt from reconﬁguring the test as a validation tool for treatment
decisions (rather than as a diagnostic aide for fevers or re-
spiratory infections), we concede that our study has only been
one of the ﬁrst steps toward a better social understanding of
clinical interventions to address antibiotic use. We, therefore,
hope that the lessons from this enquiry will not only inform
clinical research and the implementation of POCT solutions in
LMIC contexts, but also stimulate more comparative social
research against the backdrop of AMR.
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